医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro Annual Report For Fiscal Year Ended March 31, 2013 on Form 20-F Available

2013年07月02日 PM07:25
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report for fiscal year ended March 31, 2013 on Form 20-F, filed with the Securities and Exchange Commission (the “SEC”) today, is available within the Investor Relations section of Taro’s website at www.taro.com. Hard copies of the report may be ordered free of charge by sending requests to Taro Pharmaceuticals U.S.A., Inc., Three Skyline Drive, Hawthorne, NY 10532, attention: William J. Coote or via email to William.Coote@Taro.com.

Additionally, the report may be accessed on the SEC’s website at www.sec.gov.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.

CONTACT

Taro Pharmaceutical Industries Ltd.
William J. Coote, 914-345-9001
VP,
Treasurer
William.Coote@Taro.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Kaplan Test Prep and CBLA Collaborate to Publish First Official OET Study Guide
  • Analytics 4 Life®的医学顾问委员会新增全球心内科专家
  • BRIC HOLDING Offers Aimedis – ICO: Germany’s Leading eHealth Platform Goes Public
  • Research Paper Co-authored by Dr. Damien Bates, Chief Medical Officer and Head of Medical Research at SanBio Group, Published in Stroke
  • Clinigen signs agreement with Nordic Pharma for aprotinin